Hydroxyzine for Insomnia: Guideline-Based Recommendations
Guideline-Based Recommendations
- The 2019 VA/DoD guidelines strongly advise against antihistamines for chronic insomnia disorder, noting that no studies met inclusion criteria for their use as insomnia interventions 1
- The 2017 American Academy of Sleep Medicine guidelines specifically recommend against diphenhydramine (a similar antihistamine) at 50 mg doses for sleep onset or maintenance insomnia 2
- Tolerance develops rapidly after only 3-4 days of continuous antihistamine use, eliminating any potential short-term benefit 1
- The 2019 Beers Criteria carry a strong recommendation to avoid antihistamines in older adults due to their antimuscarinic adverse effect profile 1
Important Safety Considerations
- Additive CNS depression occurs with concurrent use of other sedatives, alcohol, or CNS depressants 3
- Not recommended during pregnancy or nursing 3
- Elderly patients require caution and downward dosage adjustment due to anticholinergic effects 3
- Avoid in patients with compromised respiratory function (asthma, COPD, sleep apnea) 3
- Administer on an empty stomach to maximize effectiveness 3
Guideline-Recommended Alternatives
- Eszopiclone: 2-3 mg for sleep onset and maintenance 2
- Zolpidem: 10 mg for sleep onset and maintenance 2
- Doxepin: 3-6 mg for sleep maintenance 2
- Ramelteon: 8 mg for sleep onset 2
- Temazepam: 15 mg for sleep onset and maintenance 2
- Established efficacy in randomized controlled trials 2
- Known safety profiles with appropriate monitoring 2
- Specific indications for insomnia treatment 2
Common Pitfalls to Avoid
- Do not assume antihistamines are safer than approved hypnotics simply because they are available over-the-counter 1
- Do not continue hydroxyzine beyond 3-4 days if prescribed, as tolerance eliminates sedative effects 1
- Do not use in elderly patients without considering Beers Criteria warnings about anticholinergic burden 1